Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 16;20(1):518.
doi: 10.1186/s12879-020-05202-4.

Validation of the T86I mutation in the gyrA gene as a highly reliable real time PCR target to detect Fluoroquinolone-resistant Campylobacter jejuni

Nereyda Espinoza  1 , Jesús Rojas  2 , Simon Pollett  2 , Rina Meza  2 , Lilian Patiño  3 , Manuel Leiva  4 , Máximo Camiña  5 , Manuela Bernal  2 , Nathanael D Reynolds  6 , Ryan Maves  7 , Drake H Tilley  7 , Matthew Kasper  2 , Mark P Simons  6
Affiliations

Validation of the T86I mutation in the gyrA gene as a highly reliable real time PCR target to detect Fluoroquinolone-resistant Campylobacter jejuni

Nereyda Espinoza et al. BMC Infect Dis. .

Abstract

Background: Campylobacter jejuni is a leading cause of bacterial diarrhea worldwide, and increasing rates of fluoroquinolone (FQ) resistance in C. jejuni are a major public health concern. The rapid detection and tracking of FQ resistance are critical needs in developing countries, as these antimicrobials are widely used against C. jejuni infections. Detection of point mutations at T86I in the gyrA gene by real-time polymerase chain reaction (RT-PCR) is a rapid detection tool that may improve FQ resistance tracking.

Methods: C. jejuni isolates obtained from children with diarrhea in Peru were tested by RT-PCR to detect point mutations at T86I in gyrA. Further confirmation was performed by sequencing of the gyrA gene.

Results: We detected point mutations at T86I in the gyrA gene in 100% (141/141) of C. jejuni clinical isolates that were previously confirmed as ciprofloxacin-resistant by E-test. No mutations were detected at T86I in gyrA in any ciprofloxacin-sensitive isolates.

Conclusions: Detection of T86I mutations in C. jejuni is a rapid, sensitive, and specific method to identify fluoroquinolone resistance in Peru. This detection approach could be broadly employed in epidemiologic surveillance, therefore reducing time and cost in regions with limited resources.

Keywords: Antimicrobial resistance; Campylobacter jejuni; Ciprofloxacin; T86I; gyrA.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no financial, institutional or other relationships that might lead to bias or a conflict of interest.

References

    1. Nachamkin I, Szymanski CM, Blaser MJ. Campylobacter. 3. Washington, DC: ASM Press; 2008. p. 716.
    1. Allos BM. Campylobacter jejuni infections: update on emerging issues and trends. Clin Infect Dis. 2001;32(8):1201–1206. doi: 10.1086/319760. - DOI - PubMed
    1. Kirkpatrick BD, Tribble DR. Update on human campylobacter jejuni infections. Curr Opin Gastroenterol. 2011;27(1):1–7. doi: 10.1097/MOG.0b013e3283413763. - DOI - PubMed
    1. Lee G, Paredes Olortegui M, Peñataro Yori P, Black RE, Caulfield L, Banda Chavez C, et al. Effects of Shigella-, campylobacter- and ETEC-associated diarrhea on childhood growth. Pediatr Infect Dis J. 2014;33(10):1004–1009. doi: 10.1097/INF.0000000000000351. - DOI - PubMed
    1. Francois R, Yori PP, Rouhani S, Salas MS, Olortegui MP, Trigoso DR, Pisanic N, Burga R, Meza R, et al. The other Campylobacter: Not innocent bystanders in endemic diarrhea and dysentery in children in low-income settings. PLOS Neglected Tropical Dis. 2018;12(2):e0006200. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources